Skye Bioscience, Inc. Accrued Liabilities, Current
Skye Bioscience, Inc. (SKYE) had Accrued Liabilities, Current of $5.46 thousand as of 2020-12-31, per its 10-K filed 2021-03-02.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2021-03-02
- 2020-12-31: Accrued Liabilities, Current $5.46K.
- 2020-09-30: Accrued Liabilities, Current $81.81K.
- 2020-06-30: Accrued Liabilities, Current $37.73K.
- 2020-03-31: Accrued Liabilities, Current $35.65K.
| Period end | Accrued Liabilities, Current | Accrued Liabilities, Current as first filed |
|---|---|---|
| 2020-12-31 | $5.46K 10-K · filed 2021-03-02 | |
| 2020-09-30 | $81.81K 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $37.73K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $35.65K 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $77.94K 10-K · filed 2021-03-02 | |
| 2019-03-31 | $154.93K 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $118.25K 10-Q · filed 2019-05-10 | |
| 2018-09-30 | $101.49K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $60.52K 10-Q · filed 2018-08-10 | |
| 2018-03-31 | $78.24K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $143.83K 10-K · filed 2019-03-14 | |
| 2017-09-30 | $115.49K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $201.11K 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $352.56K 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $98.70K 10-K · filed 2018-03-19 | |
| 2016-09-30 | $135.38K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $166.74K 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $156.03K 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $228.65K 10-K · filed 2017-03-10 | |
| 2015-09-30 | $177.08K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $177.54K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $158.06K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $125.80K 10-K · filed 2016-03-21 | $225.80K 10-K · filed 2015-03-27 |
| 2014-09-30 | $349.51K 10-Q · filed 2014-11-14 | |
| 2013-12-31 | $180.00K 10-K · filed 2015-03-27 | |
| 2013-07-31 | $64.25K 10-Q · filed 2013-09-16 | |
| 2013-04-30 | $52.93K 10-Q · filed 2013-06-27 | |
| 2012-10-31 | $4.33K 10-Q · filed 2013-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |